Chi Sarah Jensen
About Chi Sarah Jensen
Chi Sarah Jensen is the Director of Clinical Operations at BeiGene in Australia, with extensive experience in drug development and research.
Company
Chi Sarah Jensen is currently employed at BeiGene, where she serves as the Director of Clinical Operations in Australia. BeiGene is a biopharmaceutical company specializing in developing innovative molecularly targeted and immuno-oncology drugs for treating cancer.
Title
Chi Sarah Jensen holds the position of Director Clinical Operations at BeiGene in Australia. In this role, she oversees the clinical operations and ensures the successful planning, execution, and completion of clinical trials.
Education and Expertise
Chi Sarah Jensen pursued her higher education at Texas Women's University in Dallas, where she garnered a B.S. in Biology and an M.S. in Molecular Biology. Complementing her academic journey, she also holds a License de Physiologie from the University of Sciences in Nice, France. Additionally, she studied at the University of Tasmania from 2000 to 2002.
Background
Chi Sarah Jensen brings extensive experience in the research and development sector, with a notable tenure at Schering Plough spanning 13 years, during which she held roles of increasing responsibilities. Her career trajectory also includes significant contributions at Novartis over 15 years, where she played pivotal roles including Senior Vice President and Global Head of Drug Development Quality.
Achievements
Throughout her career, Chi Sarah Jensen has achieved several milestones, particularly during her time at Novartis where she served in a senior leadership capacity as the Global Head of Drug Development Quality. Her professional journey reflects a commitment to advancing clinical research and development in the pharmaceutical industry.